Add to ORKG<em>The authors review the application peculiarities of augmentin combined antibiotic (amoxicillin + clavulanic acid), analyze its efficacy during the exacerbation of the chronic obstruction bronchopulmonary process among children. They provide indications, contraindications and intake peculiarities of the given medication among children.</em><br /><strong><em>Key words: amoxicillin, clavulanic acid, chronic obstruction lung diseases, exacerbation, children.</em></strong
The prevalence of bacterial infections of the respiratory tract, especially in children, the presenc...
The paper covers a problem of recurrent respiratory infections (RRI) in children. Their description,...
Antibiotics are the most prescribed drugs in children, often administered without any specific diagn...
Combination of amoxicillin/clavulanate firstly occurred on a pharmacological market in 1977 and it i...
Research goal — comparative evaluation of efficiency of amoxicillin/clavulanat versus unprotected pe...
This study investigated the effects of c1avulanate-potentiated amoxyciJIin in the management of mode...
More than half a century ago, clinicians first encountered real difficulties in the treatment of inf...
The article deals with the findings of the expert appraisal of the patient medical records of 781 ch...
SUMMARY The pharmacokinetics and clinical efficacy of amoxycillin combined with clavulanic acid in t...
Sixty children under 2 years of age suffering from bronchopneumonia were evaluated for the effective...
The efficacy and safety of intravenous and sequential intravenous-oral clavulanate-potentiated amoxy...
WHO recommendations for the management of Community Acquired Pneumonia (CAP) have been revised since...
<em>The article considers application peculiarities of halixomucolytic medication (Ambroxol, Egis, H...
The article is devoted to the role of inhibitor-protected aminopenicillins in the treatment of commu...
PubMedID: 18932040Chronic lung diseases are one of the considerable problems in childhood both for p...
The prevalence of bacterial infections of the respiratory tract, especially in children, the presenc...
The paper covers a problem of recurrent respiratory infections (RRI) in children. Their description,...
Antibiotics are the most prescribed drugs in children, often administered without any specific diagn...
Combination of amoxicillin/clavulanate firstly occurred on a pharmacological market in 1977 and it i...
Research goal — comparative evaluation of efficiency of amoxicillin/clavulanat versus unprotected pe...
This study investigated the effects of c1avulanate-potentiated amoxyciJIin in the management of mode...
More than half a century ago, clinicians first encountered real difficulties in the treatment of inf...
The article deals with the findings of the expert appraisal of the patient medical records of 781 ch...
SUMMARY The pharmacokinetics and clinical efficacy of amoxycillin combined with clavulanic acid in t...
Sixty children under 2 years of age suffering from bronchopneumonia were evaluated for the effective...
The efficacy and safety of intravenous and sequential intravenous-oral clavulanate-potentiated amoxy...
WHO recommendations for the management of Community Acquired Pneumonia (CAP) have been revised since...
<em>The article considers application peculiarities of halixomucolytic medication (Ambroxol, Egis, H...
The article is devoted to the role of inhibitor-protected aminopenicillins in the treatment of commu...
PubMedID: 18932040Chronic lung diseases are one of the considerable problems in childhood both for p...
The prevalence of bacterial infections of the respiratory tract, especially in children, the presenc...
The paper covers a problem of recurrent respiratory infections (RRI) in children. Their description,...
Antibiotics are the most prescribed drugs in children, often administered without any specific diagn...